³Ô¹ÏÍøÕ¾

Latest colorectal News

Increased medicines access continues following budget boost
Bowel Cancer Breakthrough
Too much lactate can harm our health – these microbes in our gut keep it in check
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
For 50,000 Australians October 5 is the one day each year when they can be seen and heard
Surgical researchers compete for Louis Barnett Prize 2024
Considering race in colon cancer prediction reduces disparities
Asbestos study highlights risk of ACT residents developing cancer
Hon Dr Shane Reti: ³Ô¹ÏÍøÕ¾ delivers first cancer medicines from $604m boost
New knowledge about cell receptors paves the way for new drugs against intestinal tumours
Chimeric says first patient dosed in trial of CDH17-directed CAR-T cell therapy
Caroline Nordenvall awarded twice at the Surgeons’ Week 2024
All the reasons a cup of coffee really can be good for you
Chimeric says Phase 1/2 CHM CDH17 CAR-T GMP manufacturing complete
Dan L Duncan Comprehensive Cancer Center launches Phase 1 Clinical Trial Program
Riding High After Robotic Surgery
Chimeric Therapeutics says first patient enrolled in cell therapy trial
³Ô¹ÏÍøÕ¾ Bowel Screening Programme reaches 2 million life-saving screening kits
Promising Role Of Antidiabetic Drug In Cancer Control
How Research In Common Cancers Is Helping Rare Cancers
Identifying the initial steps in colorectal cancer formation
Colon cancer rates are rising in young Americans, but insurance barriers are making screening harder
Exploring the effect of H2O2 eustress on individual cancer cells using hopping probe scanning ion conductance microscopy (HPICM)
Gut microbiome: meet E coli – the infamous bacteria with an unfair reputation
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
Gut microbiome: meet Clostridium butyricum – the bacteria that helps keep us feeling our best
Future Cancer Treatment And Fertility
Losing weight associated with an increased cancer risk – a closer look at the study
Hamming it up: What’s the verdict on processed meat?
Deflexifol clinical data presented at ASCO Gastrointestinal Cancers Symposium
Vigilance needed to curb “entirely preventable” road deaths in 2024
Manchester researchers develop first ever guideline for cancer screening in rare muscle disease
Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy
Aggressive colon tumor may be vulnerable to cholesterol therapy
Even small amounts of physical activity could be valuable in late-stage lung cancer
Kate teaches ‘Art from heART’ to Mater patients
Second da Vinci system supports surgery at Mater
Wellcome Trust funds study of innate immune cells role in intestinal health and disease
Dr Ben Wylie research to develop kinder and less toxic treatments for cancer
Genetic switches in tumor development
Asbestos still risk to workers 20 years on from ban
Starpharma announces the presentation of DEP irinotecan combination data
Proud Redlands City nurse celebrates 15 years of helping patients
FivepHusion says first patient treated in paediatric brain cancer trial
Robotic masterpiece arrives at Mater Mackay
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
Engineering bacteria to detect cancer DNA
Colorectal cancer organizations unite in screening age recommendations